Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients-Reference-Cited by-同舟云学术

Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients

Published:2018-09-18 Issue:1 Volume:34 Page:207-214
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Ito Takanori¹,Ishigami Masatoshi¹,Ishizu Yoji¹^ORCID,Kuzuya Teiji¹,Honda Takashi¹,Hayashi Kazuhiko¹^ORCID,Nishimura Daisaku²,Toyoda Hidenori³,Kumada Takashi³,Goto Hidemi¹,Hirooka Yoshiki¹^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology; Nagoya University Graduate School of Medicine; Nagoya Japan

2. Department of Gastroenterology; Toyota Kosei Hospital; Toyota Japan

3. Department of Gastroenterology and Hepatology; Ogaki Municipal Hospital; Ogaki Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.14448/fullpdf

Reference35 articles.

1. The global NAFLD epidemic;Loomba;Nat. Rev. Gastroenterol. Hepatol.,2013

2. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study;Eguchi;J. Gastroenterol.,2012

3. Nonalcoholic fatty liver disease in Asia: emerging perspectives;Seto;J. Gastroenterol.,2017

4. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management;McPherson;J. Hepatol.,2015

5. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up;Ekstedt;Hepatology,2015

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Two Long Noncoding RNAs, Kcnq1ot1 and Rmst, as Biomarkers in Chronic Liver Diseases in Mice;International Journal of Molecular Sciences;2024-08-16

2. Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients;Hepatology International;2024-07-16

3. Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis;Annals of Hepatology;2024-05

4. Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis;The Kaohsiung Journal of Medical Sciences;2024-01-17

5. From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention;Cancers;2023-11-17